SCHEMBL18819260

SCHEMBL18819260

c1ccc(-c2cc(-c3cccc4ccccc34)nc(-c3cc4ccccc4cc3-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.51
▸ KMT2A Q03164 8/20 0.51
▸ MAPT P10636 5/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ HPGD P15428 5/20 0.51
▸ KDM4E B2RXH2 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ TDP1 Q9NUW8 3/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ GLA P06280 1/20 0.49
▸ NTSR1 P30989 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18818820 0.95 MEN1 (0.53) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL14725231 0.94 MAPT (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18623308 0.92 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18819166 0.91 MEN1 (0.53) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL12306181 0.90 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL10051293 0.90 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL10051196 0.90 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL10051210 0.90 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17969965 0.90 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17969961 0.90 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737357-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. 2023-08-22 — — US disclosed
US-11737357-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. 2023-08-22 — — US disclosed
US-20230255104-A1 Compound And Organic Light-Emitting Device Comprising Same LG CHEM, LTD. (KR) 2023-08-10 — — US disclosed
US-20230255104-A1 Compound And Organic Light-Emitting Device Comprising Same LG CHEM, LTD. (KR) 2023-08-10 — — US disclosed
EP-3351536-B1 ORGANIC LIGHT-EMITTING DEVICE LG CHEMICAL LTD (KR) 2021-07-21 — — EP disclosed
US-10367149-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2019-07-30 — — US disclosed
US-20190055222-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-02-21 — — US disclosed
EP-3351537-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2018-07-25 — — EP disclosed
EP-3351536-A1 ORGANIC LIGHT-EMITTING DEVICE LG Chem, Ltd. (KR) 2018-07-25 — — EP disclosed
WO-2017074052-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2017-05-04 — — WO disclosed
WO-2017074053-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2017-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11737357-B2 Compound and organic light-emitting device comprising same CRY1, CYP1B1, CYP1A1 MEN1 306/4885KMT2A 2446/4885MAPT 1315/4885
US-20230255104-A1 Compound And Organic Light-Emitting Device Comprising Same ARL1, AR, ALG3 MEN1 415/4885KMT2A 1780/4885MAPT 974/4885
US-10367149-B2 Organic light-emitting device CRY1, PPOX, CRY2 MEN1 2977/4885KMT2A 3225/4885MAPT 774/4885
US-20190055222-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1B1, CYP1A1 MEN1 306/4885KMT2A 2446/4885MAPT 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback